The emerging treatment of the medication represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide363249.designi1.com/62792802/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment